Cargando…

Impact of adaptive intensity-modulated radiotherapy on the neutrophil-to-lymphocyte ratio in patients with nasopharyngeal carcinoma

PURPOSE: Nutritional status and haematological parameters are related to the prognosis of patients treated with radiotherapy, but the correlation between adaptive radiotherapy (ART) and haematological indicators has never been reported. This study explores the influence of ART on the change in haema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Ning, Lyu, Xintong, Li, Guang, Qiao, Qiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704552/ https://www.ncbi.nlm.nih.gov/pubmed/31438994 http://dx.doi.org/10.1186/s13014-019-1350-9

Ejemplares similares

The prognostic value of the ratio of neutrophils to lymphocytes before and after intensity modulated radiotherapy for patients with nasopharyngeal carcinoma
por: Liu, Jing, et al.
Publicado: (2020)

Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intensity modulated radiation therapy for nasopharyngeal carcinoma
por: Jiang, Yanming, et al.
Publicado: (2018)

Pretreatment combination of platelet counts and neutrophil–lymphocyte ratio predicts survival of nasopharyngeal cancer patients receiving intensity-modulated radiotherapy
por: Lin, Yu-Hsuan, et al.
Publicado: (2017)

Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma
por: Lu, Aiying, et al.
Publicado: (2017)

Neutrophil-to-lymphocyte ratio predicts the prognosis of stage II nasopharyngeal carcinoma
por: Pan, Xin-Bin, et al.
Publicado: (2019)

Cutoff point of neutrophil-to-lymphocyte ratio for predicting survival in nasopharyngeal carcinoma
por: Setakornnukul, Jiraporn, et al.
Publicado: (2021)

Neutrophil–lymphocyte ratios in the prognostication of primary non-metastatic nasopharyngeal carcinoma()
por: Liew, Kong Yew, et al.
Publicado: (2017)

Analysis of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma
por: Wu, Shihai, et al.
Publicado: (2020)

Prognostic role of neutrophil–lymphocyte ratio in nasopharyngeal carcinoma: A meta-analysis
por: Takenaka, Yukinori, et al.
Publicado: (2017)

Prognostic value of neutrophil-to-lymphocyte ratio for nasopharyngeal carcinoma: A meta-analysis
por: Yin, Jun, et al.
Publicado: (2017)

Target delineation and dose prescription of adaptive replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma
por: Xie, Dehuan, et al.
Publicado: (2019)

Target volume and position variations during intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma
por: Tan, Wenyong, et al.
Publicado: (2013)

Prognostic significance of Ki67 expression and the derived neutrophil–lymphocyte ratio in nasopharyngeal carcinoma
por: Zhao, Liang, et al.
Publicado: (2018)

Predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma survivors after intensity-modulated radiotherapy
por: Zhai, Ruiping, et al.
Publicado: (2022)

Clinical characteristics and prognosis of elderly nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy
por: Lyu, Yingchen, et al.
Publicado: (2020)

Efficacy of intensity-modulated radiotherapy with concurrent carboplatin in nasopharyngeal carcinoma
por: Songthong, Anussara, et al.
Publicado: (2015)

The Effect of Prolonged Duration of Intensity Modulated Radiotherapy for Nasopharyngeal Carcinoma
por: Hua, Yi-Jun, et al.
Publicado: (2021)

Outcomes of patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
por: Yeh, Shyh-An, et al.
Publicado: (2021)

Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy
por: Wu, Shixiu, et al.
Publicado: (2015)

Effect of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy alone in nasopharyngeal carcinoma
por: OuYang, Pu-Yun, et al.
Publicado: (2016)

Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
por: Tian, Y-M, et al.
Publicado: (2014)

Local failure patterns for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy
por: Li, Jia-xin, et al.
Publicado: (2014)

Paranasal Sinus Invasion in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy
por: Cao, Caineng, et al.
Publicado: (2019)

Evaluation of the Dosimetric Feasibility of Hippocampal Sparing Intensity-Modulated Radiotherapy in Patients with Locally Advanced Nasopharyngeal Carcinoma
por: Han, Guang, et al.
Publicado: (2014)

Prognostic Value of the Neutrophil-to-Lymphocyte Ratio before and after Radiotherapy for Anaplastic Thyroid Carcinoma
por: Park, Jiyun, et al.
Publicado: (2021)

Prognostic Significance of the Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Neuroendocrine Carcinoma
por: Kim, Hyeon-Jong, et al.
Publicado: (2022)

Prognostic Significance of Tumor Volume in Locally Recurrent Nasopharyngeal Carcinoma Treated with Salvage Intensity-Modulated Radiotherapy
por: Xiao, WeiWei, et al.
Publicado: (2015)

Longitudinal measurements of neutrophil-to-lymphocyte ratio in nasopharyngeal cancer treated with concurrent chemoradiotherapy
por: Muangwong, Pooriwat, et al.
Publicado: (2023)

Results of the radiation dose of head, body and tail of hippocampus in nasopharyngeal carcinoma patients treated with intensity modulated radiotherapy
por: Zong-wen, Sun, et al.
Publicado: (2018)

Apolipoprotein A-I Is a Prognosticator of Nasopharyngeal Carcinoma in the Era of Intensity-modulated Radiotherapy
por: Chang, Hui, et al.
Publicado: (2018)

Effectiveness and Toxicities of Intensity-Modulated Radiotherapy for Patients with Locally Recurrent Nasopharyngeal Carcinoma
por: Chen, Hai-yan, et al.
Publicado: (2013)

Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma
por: Yi, Junlin, et al.
Publicado: (2014)

Concurrent Chemotherapy for T4 Classification Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy
por: Cao, Cai-neng, et al.
Publicado: (2015)

Incidence of and Risk Factors for Mastoiditis after Intensity Modulated Radiotherapy in Nasopharyngeal Carcinoma
por: Yao, Ji-Jin, et al.
Publicado: (2015)

Predictors for improvement of xerostomia in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy
por: Pan, Xin-Bin, et al.
Publicado: (2019)

Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy
por: Pan, Xin-Bin, et al.
Publicado: (2020)

Multivariate NTCP Model of Hypothyroidism After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
por: Shen, Guanzhu, et al.
Publicado: (2021)

Second Primary Lung Adenocarcinoma After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
por: Xue, Fen, et al.
Publicado: (2022)

Patterns and prognosis of regional recurrence in nasopharyngeal carcinoma after intensity‐modulated radiotherapy
por: Xiao, Xiao‐Tang, et al.
Publicado: (2022)

Efficacy and safety of intensity-modulated radiotherapy alone versus intensity-modulated radiotherapy plus chemotherapy for treatment of intermediate-risk nasopharyngeal carcinoma
por: Aftab, Omer, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sar0cgcktgov7rvpt4ro455i80